Janux Therapeutics, Inc. (JANX) Earnings
|
Expand Research on JANX
| Next EPS Date | 8/12/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -0.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/12/26  |
Q126 | N/A | -$0.66 | N/A | N/A | $746.15K | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | -$0.51 | -$0.62 | +$0.11 | N/A | $142.86K | N/A |  | | Details | |
| 11/6/25 |
Q325 | -$0.39 | -$0.62 | +$0.23 | $10M | $2.88M | N/A | | | Details | |
| 8/12/25 |
Q225 | N/A | -$0.46 | N/A | N/A | $272.73K | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | -$0.38 | -$0.37 | -$0.01 | N/A | $363.64K | N/A | | | Details | |
| 3/7/25 |
Q424 | N/A | -$0.43 | N/A | N/A | $1.15M | N/A | N/A | N/A | ||
| 11/7/24 | Q324 | -$0.51 | -$0.33 | -$0.18 | $440K | $755K | N/A | | | Details | |
| 8/8/24 | Q224 | -$0.11 | -$0.31 | +$0.20 | $8.89M | $772K | N/A | | | Details |
